These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1134 related items for PubMed ID: 12934082
1. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells. Hermisson M, Weller M. Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082 [Abstract] [Full Text] [Related]
2. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB. Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ. Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027 [Abstract] [Full Text] [Related]
3. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release. Röhn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H, Weller M. Oncogene; 2001 Jul 12; 20(31):4128-37. PubMed ID: 11464279 [Abstract] [Full Text] [Related]
4. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R, Bedi A. Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014 [Abstract] [Full Text] [Related]
5. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis. Kim HS, Chang I, Kim JY, Choi KH, Lee MS. Cancer Res; 2005 Jul 15; 65(14):6111-9. PubMed ID: 16024612 [Abstract] [Full Text] [Related]
6. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release. Hermisson M, Wagenknecht B, Wolburg H, Glaser T, Dichgans J, Weller M. Oncogene; 2000 May 04; 19(19):2338-45. PubMed ID: 10822385 [Abstract] [Full Text] [Related]
7. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X, Kandasamy K, Srivastava RK. Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723 [Abstract] [Full Text] [Related]
8. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. Gao X, Deeb D, Jiang H, Liu YB, Dulchavsky SA, Gautam SC. J Exp Ther Oncol; 2005 Mar 01; 5(1):39-48. PubMed ID: 16416600 [Abstract] [Full Text] [Related]
9. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines. Guseva NV, Taghiyev AF, Sturm MT, Rokhlin OW, Cohen MB. Mol Cancer Res; 2004 Oct 01; 2(10):574-84. PubMed ID: 15498932 [Abstract] [Full Text] [Related]
10. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Pollack IF, Erff M, Ashkenazi A. Clin Cancer Res; 2001 May 01; 7(5):1362-9. PubMed ID: 11350907 [Abstract] [Full Text] [Related]
11. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP, Zisman A, Bonavida B. Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140 [Abstract] [Full Text] [Related]
12. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K, Douglas L, Delaney AB, Houghton JA. Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213 [Abstract] [Full Text] [Related]
13. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. Cancer Res; 2005 Aug 15; 65(16):7436-45. PubMed ID: 16103097 [Abstract] [Full Text] [Related]
14. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB. Schmelz K, Wieder T, Tamm I, Müller A, Essmann F, Geilen CC, Schulze-Osthoff K, Dörken B, Daniel PT. Oncogene; 2004 Sep 02; 23(40):6743-59. PubMed ID: 15273737 [Abstract] [Full Text] [Related]
15. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
16. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL). Pawlowski JE, Nesterov A, Scheinman RI, Johnson TR, Kraft AS. Anticancer Res; 2000 Oct 01; 20(6B):4243-55. PubMed ID: 11205254 [Abstract] [Full Text] [Related]
17. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Knight MJ, Riffkin CD, Muscat AM, Ashley DM, Hawkins CJ. Oncogene; 2001 Sep 13; 20(41):5789-98. PubMed ID: 11593384 [Abstract] [Full Text] [Related]
18. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Roth W, Wagenknecht B, Klumpp A, Naumann U, Hahne M, Tschopp J, Weller M. Cell Death Differ; 2001 Apr 13; 8(4):403-10. PubMed ID: 11550092 [Abstract] [Full Text] [Related]
19. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Chopin V, Slomianny C, Hondermarck H, Le Bourhis X. Exp Cell Res; 2004 Aug 15; 298(2):560-73. PubMed ID: 15265702 [Abstract] [Full Text] [Related]
20. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in androgen-independent prostate cancer cells. Yu R, Mandlekar S, Ruben S, Ni J, Kong AN. Cancer Res; 2000 May 01; 60(9):2384-9. PubMed ID: 10811114 [Abstract] [Full Text] [Related] Page: [Next] [New Search]